Radar Telegram alerts Open Radar

President ordered to include HPV vaccine in national calendar through home vaccination Russian President Vladimir Putin directed the Russian Ministry of Health to expand the national preventive vaccination calendar to include human papillomavirus (HPV) vaccine. At the same time, the department must ensure the use of home vaccines. The appropriate provision was included in the list approved following the meeting of the Presidential Council for the Implementation of the State's Demographic and Family Policy, which took place on May 29, 2026. Minister of Health Mikhail Murshko was appointed responsible. The deadline for submitting the report is June 1, 2027. The first quadrivalent vaccine against HPV has already been registered in Russia - Tsegardex from Nanolac. The drug is intended for the prevention of diseases caused by virus types 6, 11, 16 and 18. In March 2025, the vaccine received registration for use in adults, and in January 2026, the Russian Ministry of Health approved its use in children aged 9 to 17 years. Previously, the inclusion of the HPV vaccine in the national calendar was already planned for 2027. The new presidential decree establishes the requirement for the use of the Russian drug and establishes a reporting period to the Russian Ministry of Health. Read us in Max Telegram VK.

Право на здоровье · · Source

🇷🇺 Russia · Map

President ordered to include HPV vaccine in national calendar through home vaccination Russian President Vladimir Putin directed the Russian Ministry of Health to expand the national preventive vaccination calendar to include human papillomavirus (HPV) vaccine. At the same time, the department must ensure the use of home vaccines. The appropriate provision was included in the list approved following the meeting of the Presidential Council for the Implementation of the State's Demographic and Family Policy, which took place on May 29, 2026. Minister of Health Mikhail Murshko was appointed responsible. The deadline for submitting the report is June 1, 2027. The first quadrivalent vaccine against HPV has already been registered in Russia - Tsegardex from Nanolac. The drug is intended for the prevention of diseases caused by virus types 6, 11, 16 and 18. In March 2025, the vaccine received registration for use in adults, and in January 2026, the Russian Ministry of Health approved its use in children aged 9 to 17 years. Previously, the inclusion of the HPV vaccine in the national calendar was already planned for 2027. The new presidential decree establishes the requirement for the use of the Russian drug and establishes a reporting period to the Russian Ministry of Health. Read us in Max Telegram VK.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram